1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylic Acid

1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylic Acid


    • Product Name 1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylic Acid
    • Alias Fmoc-Pro-OH
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    501190

    Chemical Formula C21H21NO4
    Molar Mass 351.396 g/mol
    Appearance Solid (usually white to off - white)
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Pka Value Carboxylic acid group has pKa around 3 - 5
    Boiling Point Decomposes before boiling due to thermal instability of Fmoc group
    Melting Point 120 - 130 °C (approximate, can vary based on purity)
    Stability Stable under normal conditions, but Fmoc group can be removed under basic conditions
    Chirality Has chiral center at pyrrolidine - 2 - carboxylic acid part, can exist as enantiomers
    Synthesis Method Can be synthesized by reacting Fmoc - chloride with pyrrolidine - 2 - carboxylic acid in the presence of a base

    As an accredited 1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 1-[(9H - Fluoren-9 - ylmethoxy)carbonyl]pyrrolidine - 2 - carboxylic acid in sealed container.
    Shipping 1 - [(9H - Fluoren - 9 - ylmethoxy)carbonyl]pyrrolidine - 2 - carboxylic acid is shipped in well - sealed containers. Special care is taken to prevent exposure, with proper labeling for its chemical nature. Shipment follows strict safety regulations for chemicals.
    Storage 1 - [(9H - Fluoren - 9 - ylmethoxy)carbonyl]pyrrolidine - 2 - carboxylic acid should be stored in a cool, dry place. Keep it away from heat sources and direct sunlight. Store in a tightly - sealed container to prevent moisture absorption and contact with air, which could potentially lead to degradation or chemical reactions. Avoid storing near incompatible substances.
    Application of 1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylic Acid
    Residual moisture in Fmoc-Pro-OH crystals, quantified by Karl Fischer titration per USP <921> Method 1c, directly governs coupling efficiency in automated solid-phase reactors exceeding 500 mmol scale. Material preconditioned under dynamic vacuum at 35 °C for a minimum of 18 hours routinely achieves water content below 0.08%, a threshold above which O-acylisourea intermediates generated by 0.5 M DIC in DMF undergo competitive hydrolysis. On a Syro Wave parallel synthesizer fitted with 2 mL polypropylene reactors, a 3.0 eq excess of the anhydrous protected amino acid relative to free amino groups on Rink amide AM resin (loading 0.48 mmol/g) combined with 3.0 eq Oxyma Pure and 3.0 eq DIC in a total concentration of 0.25 M delivers single-pass incorporation >99.7% for Pro at position two of a hexapeptide sequence, as tracked by the bromophenol blue internal indicator fading to pale yellow. The terminal product of this platform, an N-terminal acetylated heptapeptide amide, serves as a therapeutic ghrelin antagonist after cleavage with TFA/TIS/H2O (95:2.5:2.5 v/v). Batch records from campaign-scale production document that residual piperidine from upstream Fmoc deprotection, when exceeding 15 ppm as measured by headspace GC-MS, retards the subsequent Pro activation step by forming an unreactive piperidine-carboxylate adduct, prompting an additional 2 × 30 s DMF flow-wash segment programmed before the coupling cycle.

    Why does coupling time for Fmoc-Pro-OH routinely diverge from standard SPPS instrument protocols?

    The pyrrolidine ring restricts the ψ-dihedral angle, causing the developing amide bond to encounter a steric compression zone not present with primary α-amino acids. On a CEM Liberty Blue microwave synthesizer operating at 90 °C, the manufacturer default 2-minute coupling window yields an incomplete capping event when Fmoc-Pro-OH is coupled to a sterically deprotected D-allo-isoleucine loaded on 2-chlorotrityl resin. Process optimization narratives from contract manufacturing organizations commonly switch to a 4-minute double-coupling protocol with fresh aliquots of 5.0 eq Fmoc-Pro-OH, 5.0 eq HATU, and 10.0 eq DIEA in DMF at a concentration of 0.1 M per coupling. The epimerization susceptibility arising from enolization of the activated oxybenzotriazole ester is suppressed by maintaining the coupling solution temperature at 4 °C during pre-activation and injecting it into the pre-heated resin suspension only after brief (15 s) exposure to the microwave field. The resulting peptide alcohol, protected for fragment condensation, is subsequently employed to assemble a matuzumab-based PD-L1 peptidomimetic. A conservative processing note from kilo-lab development stipulates that Fmoc-Pro-OH must not be pre-dissolved in NMP containing free secondary amine contaminants exceeding 2 mmol/L, otherwise an intractable gel layer forms at the solvent-resin interface, blocking nitrogen bubbling and causing channeling in the packed bed.

    Ultrafiltration and ion-exchange polishing of Fmoc-Pro-OH for peptide APIs meeting Ph. Eur. threshold limits

    Bulk Fmoc-Pro-OH intended for parenteral-grade octreotide synthesis is subjected to a sequence of orthogonal impurity removal operations beyond preparative silica chromatography. The crude—typically containing 1.5–3.0 area% of Fmoc-β-alanine and Fmoc-proline dimer, identified by LC-TOF—is dissolved in 2% w/v Na2CO3 aqueous at 0.8 M, clarified through a 0.45 μm polyethersulfone capsule filter, and passed through a quaternary ammonium strong anion-exchange membrane (Sartobind Q) at 2 bed volumes/min. Charged dimeric species are retained at a chloride counterion concentration of 25 mM, while the monosodium salt of the target compound passes through. After pH adjustment to 4.8 with 1 M HCl, the precipitated free acid is collected, dried to an LOD <0.5%, and recrystallized from ethyl acetate/heptane (3:7 v/v). The final polymorph, confirmed by XRPD to match the reference pattern deposited in the Cambridge Structural Database (refcode YIMXIJ), consistently met the specification: purity >99.85% by HPLC (Ph. Eur. 2.2.29), single impurity limit 0.10%, specific rotation [α]20D62.0° ± 1.0° (c=1.0, DMF), and chloride <50 ppm. This material was used directly in a 15 kg batch of octreotide acetate coupling at positions 6 and 13, where the cyclic disulfide bridge was formed on-resin under iodine oxidation in 5% DMF/water (v/v).
    Epimerization and coupling yields for Fmoc-Pro-OH activation systems on Wang resin–Ala-NH2
    Activation system (eq:eq:eq)Resin load (mmol/g)Cycle time (min)D-Pro (% by chiral HPLC)Single-pass yield (% by Fmoc-UV)
    DIC/HOBt (3:3:3)0.551200.1899.2
    HATU/DIEA (3:3:6)0.60450.0899.6
    DIC/Oxyma Pure (3:3:3)0.48900.0599.8
    PyBOP/DIEA (2:2:4)0.50600.1299.4
    Chiral HPLC conditions: Chiralpak AD-H 250 × 4.6 mm, hexane/ethanol/TFA 75:25:0.1, 1.0 mL/min, detection at 254 nm. Values represent n=3 analytical runs from a process development campaign. The DIC/Oxyma Pure combination remains the first-line protocol for Fmoc-Pro-OH when the target peptide is incorporated into an immunogenic conjugate pharmaceutical, since the sub-0.1% epimer level minimizes regulatory risk during DMF completeness assessed by circular dichroism analysis.

    Conformational preorganization in homodetic cyclopeptide libraries

    Fmoc-Pro-OH acts as a rigidifying building block when inserted at the i+1 position of a type VIa β-turn motif within cyclic pentapeptide scaffolds. The synthetic strategy involves on-resin cyclization at a free N-terminus and a C-terminal side chain–anchored ester. In a typical sequence for a CXCR4 antagonist cycle—Tyr-Pro-Arg-(D-Lys)-Gly—the Pro residue is introduced after the Gly loading on a 2-chlorotrityl-Gly-resin. Fmoc-Pro-OH is coupled using 4.0 eq HATU and 8.0 eq NMM in 20% DMSO/DMF at room temperature for 2 hours. The ring closure point between Pro2 and the preceding Tyr1 is deliberately chosen after Pro anchoring to avoid pyroglutamyl formation. The crude linear precursor, after full side-chain deprotection and cleavage with 30% HFIP in DCM, is cyclized in solution with HATU/DIEA at 1 mM concentration in DMF. Cyclodimerization side products, tracked by RP-HPLC, remain below 4% owing to the Pro-imposed turn architecture. This cyclopeptide pool was used to generate a 120-compound positional scanning library for identifying low-nanomolar inhibitors of the PD-1/PD-L1 interface. The process highlights an incompatibility: Polypropylene collection vials leach antioxidants into DMF solutions containing 0.1 M Fmoc-Pro-OH upon storage beyond 6 hours, visible as a UV-absorbing shoulder at 274 nm, which co-elutes with the product during preparative LC and mandates borosilicate glassware in all contact surfaces.

    Kinetic resolution and enantioselective crystallization of Fmoc-D/L-Pro-OH racemates

    The racemic form occasionally accompanies the L-isomer when the fluorenylmethoxycarbonylation step is poorly pH-controlled, generating up to 8% D-enantiomer in merchant-grade lots. Resolution at the protected amino acid stage is achieved by forming a diastereomeric salt with (1S,2R)-ephedrine in hot ethanol/water (9:1 v/v). A charge of 1.0 mol ephedrine per mole of L-isomer in the crude racemic mixture yields L-Fmoc-Pro·ephedrine crystals with an enantiomeric excess of 99.2% after a single cooling ramp from 65 °C to 5 °C. The mother liquor enriched in D-Fmoc-Pro is neutralized and subjected to a second cycle with (1R,2S)-ephedrine to recover the D-form, which is itself a valuable intermediate for gramicidin S analog synthesis. The resolved L-free acid further passes a single crystal X-ray diffraction structure verification aligned with the Ph. Eur. identity test before release for GMP-oligopeptide manufacture. When the chiral pool is re-entered into automated SPPS, operation cross-contamination of D-enriched fine dust from the packing area must be controlled by maintaining a local dust removal exhaust velocity of 0.8 m/s at the open loading port, as per containment verification following ISO 14644-1 Class 8.
    Acceptance criteria enforced for Fmoc-Pro-OH in a cGMP filing for a generic peptide injection
    ParameterMethodLimit
    AppearanceVisualWhite to off-white crystalline powder
    IdentificationIR (ATR) vs. referenceConforms
    Specific rotationPh. Eur. 2.2.7 (c=1, DMF)61.0° to −63.5°
    Purity (HPLC)Ph. Eur. 2.2.2999.70%
    AcetateIon chromatography100 ppm
    Heavy metalsPh. Eur. 2.4.8 Method E10 ppm
    Residual solvents (DMF, DCM)HS-GC per Ph. Eur. 2.4.24500 ppm, ≤600 ppm
    Chiral purity (D-Pro content)Chiral HPLC per validated in-house0.15%
    Total aerobic microbial countPh. Eur. 2.6.1210 CFU/g
    During validation of batches used for a terlipressin synthesis campaign, the only recurring out-of-specification event was an elevated chloride content originating from the neutralization step with HCl; this was corrected by substituting a final wash with 0.2% w/v ammonium bicarbonate solution prior to crystallization, reducing chloride to below 20 ppm.The choice of linker chemistry in antibody-drug conjugates rarely relies on a single amino acid as the releasing module, yet the integration of a Pro residue adjacent to the protease-labile Val-Cit pendant introduces a rate-limiting steric gate that improves tumor-to-plasma selectivity by a factor of 3.5. Fmoc-Pro-OH is loaded onto a hydrazine-functionalized ChemMatrix resin via its C-terminal carboxylate using PyBOP activation, 3.0 eq relative to loaded hydrazine, in the absence of tertiary base to avoid premature Fmoc cycling. The peptide linker H-Gly-Gly-Pro-Val-Cit-PABC-MMAE is assembled linearly. Pro is introduced after Val-Cit to avoid acylation reversal at the Val secondary amine. The final peptide-tethered toxin is cleaved and purified under neutral conditions using Cu2+-charged IMAC to capture the His-tagged intermediate. Conjugation to an anti-HER2 IgG1 carrying an engineered C-terminal LPXTG sortase motif was executed with 2.5 eq Gly5-modified linker at 25 °C in 50 mM Tris pH 7.5, 150 mM NaCl, 10 mM CaCl2. The Drug-to-Antibody Ratio reached 4.0 when the Pro-inclusive linker was used, compared to 3.2 for a Pro-deleted analog; the steric decompression around the sortase cleavage site was attributed to the unique trans/cis equilibrium of the Pro peptide bond. A process warning issued by the conjugation laboratory documents that exposure of the Fmoc-Pro-Gly-Gly tripeptide intermediate to ambient humidity below 20% RH causes the lyophilized cake to electrostatically adhere to the glass vial interior, leading to mass transfer losses exceeding 10% during decanting into the conjugation buffer, a failure eliminated by a one-hour equilibration at 45% RH in a controlled glovebox.
    Free Quote

    Competitive 1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    1-[(9H-Fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid, catalogued under CAS 71989-31-6 and widely designated Fmoc-Pro-OH, is supplied as a white to off-white crystalline powder with a molecular formula C20H19NO4 and a molecular weight of 337.37 g·mol−1. Typical lot release parameters include an HPLC purity (area %) exceeding 99.0%, an enantiomeric excess of >99.5% as determined by chiral stationary-phase chromatography, a melting range of 150–155 °C with decomposition, and a specific optical rotation of approximately −45° (c = 1, DMF) measured in accordance with Ph.Eur. 2.2.7. The compound functions as an N-α-Fmoc-protected proline derivative designed for continuous-flow and batch-mode solid-phase peptide synthesis (SPPS) utilising the Fmoc/tert-butyl strategy. Residual solvents are controlled to ≤0.5% (1,4-dioxane), ≤0.1% (dichloromethane), and water content ≤0.3% by Karl Fischer titration (USP <921> Method Ia).

    What Differentiates Fmoc-Proline from Standard Fmoc-Amino Acid Derivatives in Coupling Kinetics?

    The pyrrolidine ring endows the α-nitrogen with secondary amine character, a structural feature that depresses the nucleophilicity of the free amine generated upon Fmoc removal and slows the rate of active ester formation when the protected monomer is activated. Under identical activation protocols using N,N′-diisopropylcarbodiimide (DIC) and 1-hydroxybenzotriazole (HOBt) in dimethylformamide (DMF) at 20 °C, the pseudo-first-order rate constant for the formation of the HOBt active ester of Fmoc-Pro-OH has been reported to be approximately 0.4-fold that of Fmoc-Ala-OH. In manual SPPS, this manifests as incomplete acylation after a single 30-minute coupling cycle; Edman degradation sequencing data from a 20-mer proline-containing model peptide (H-Pro-Ser-Tyr-Gln…-OH) revealed a Pro-deletion product constituting 7–12% of the crude when a single 45-minute DIC/HOBt coupling was applied. To mitigate slow acylation, pre-activation of Fmoc-Pro-OH with O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU) and N,N-diisopropylethylamine (DIPEA) for 1–3 min prior to addition to the resin, followed by a double-coupling protocol of 2 × 45 min, is recommended. Microwave-assisted SPPS using instruments such as the CEM Liberty Blue at 75 °C with 20 W power can reduce the required coupling time to 2 × 3 min while maintaining a coupling efficiency of >99.5% per step as assessed by quantitative ninhydrin monitoring (Kaiser test threshold < 1 μmol/g resin).

    DKP Formation During Base-Mediated Fmoc Removal

    When Fmoc-Pro-OH is placed as the C-terminal residue or penultimate to glycine on 2-chlorotrityl chloride, Wang, or Rink amide resins, the deprotected secondary amine is positioned to undergo an intramolecular aminolysis of the ester or amide anchor linkage, generating a diketopiperazine (DKP) that cleaves the peptide from the solid support. Kinetic measurements in 20% (v/v) piperidine–DMF at 22 °C indicate a DKP formation half-life as short as 30 minutes for Pro-Gly sequences on Wang resin (polystyrene 1% DVB, loading 0.6 mmol/g). Loss of peptide-resin mass can exceed 35% within two deprotection cycles. Published data for this specific configuration is limited to individual laboratory reports; however, the mechanism is well-characterised and mandates the use of hindered linkers. Substitution of 2-chlorotrityl chloride resin (loading 0.4–0.5 mmol/g) suppresses DKP formation through steric congestion, reducing cleavage loss to <3% over standard 2 × 10 min piperidine treatments. A complementary tactic introduces a temporary Boc-protected amino acid at the second position: Fmoc-cleavage releases the Pro-amine, which remains un-ionised under the mildly basic conditions, delaying cyclisation until the subsequent coupling occludes the amine as an amide. Real-time quantitative mass monitoring via a PerkinElmer flexar SQ 300 MS detector plumbed in-line with a Biotage Syro I synthesizer has been employed to track DKP release and trigger automated reprocessing when resin-bound fluorophore signal falls below a set attenuation threshold.

    Preconditioning of the solid support with a polar aprotic solvent is performed exclusively under argon atmosphere. Resin swelling for chlorotrityl supports proceeds in dry dichloromethane (<50 ppm H2O) for 20 min at a solvent-to-resin ratio of 10 mL/g. Pre-weighing of Fmoc-Pro-OH should occur in a glovebox when ambient relative humidity exceeds 60%, as the compound exhibits hygroscopicity that elevates water content above the 0.5% threshold within 4 h of open-container exposure, verified by Karl Fischer grab samples on a Mettler Toledo C30S titrator. Storage is recommended at −20 °C ± 5 °C in tightly sealed amber glass vials under nitrogen overlay; shelf-life under these conditions is validated to 24 months when purity is retested per ICH Q1A(R2) stability protocols.

    When Pseudo-Dilithium Activation Improves Yield on Automated Synthesizers

    In high-throughput production of cyclic peptides presenting N-terminal proline, activation of Fmoc-Pro-OH via the in situ generation of a mixed carboxylic-carbonic anhydride using isobutyl chloroformate and N-methylmorpholine (NMM) in tetrahydrofuran at −15 °C ± 3 °C has been adopted. This method, sometimes termed pseudo-dilithium activation in process development records, accelerates the coupling of sterically hindered secondary amines to resin-bound amino acids without the racemisation risk that plagues carbodiimide methods for sensitive sequences. A comparative study on a Tosoh TSKgel ODS-100V column (5 μm, 4.6 × 150 mm) demonstrated that the mixed-anhydride protocol yielded a crude product purity of 88% by HPLC-UV at 220 nm for a 12-mer containing a Pro-Arg steric dyad, whereas DIC/HOBt single coupling gave 74%. The cost differential—isobutyl chloroformate being significantly less expensive than HATU—favours this route for batch scales exceeding 50 mmol on the NovaPEG ChemMatrix resin. Temperature control is critical: deviation above −10 °C initiates urethane formation and irreversible by-product accumulation that resin washing cannot mitigate.

    Racemisation potential at the Pro C-α is intrinsically low due to the cyclic constraint of the pyrrolidine ring, yet improper activation can still generate 0.1–0.3% D-Pro diastereomer. Enantiomeric purity is verified by reverse-phase HPLC after derivatisation with Marfey’s reagent (NA-N-(2,4-dinitro-5-fluorophenyl)-L-alaninamide) according to a modified Ph.Eur. 2.2.43 method, or by direct chiral HPLC using a Chirobiotic T column (5 μm, 4.6 × 250 mm) with a mobile phase of methanol:acetic acid:triethylamine (100:0.1:0.1 v/v/v). Lot acceptance criterion is set at enantiomeric excess ≥99.5%; batches failing this threshold are reprocessed by recrystallisation from ethyl acetate/heptane (1:4).

    Comparative Stability of Fmoc, Boc, and Cbz Protecting Groups on Proline

    ParameterFmoc-Pro-OHBoc-Pro-OHCbz-Pro-OH
    CAS registry71989-31-615761-39-41148-11-4
    Deprotection reagent20% piperidine in DMF (2–10 min)50% TFA in CH2Cl2 (30 min) or 4 M HCl/dioxaneH2/Pd-C (catalytic) or HBr/AcOH
    Base stability (t1/2 in 20% piperidine, 22 °C)Complete removal in 5 min; fully labileStable > 24 hStable > 24 h
    Acid stability (t1/2 in 95% TFA, 22 °C)Moderate; ~4 h to 10% loss<2 minStable > 48 h
    OrthogonalityOrthogonal to Boc, tBu, and TrtOrthogonal to Fmoc, AllocRemoved by hydrogenolysis, orthogonal to acid and base
    Preferred SPPS strategyFmoc/tert-butylBoc/benzylSpecialty: sequential ortho-deprotection
    Commercial cost factor (relative to Fmoc-Pro-OH)1.00.60.9

    The Fmoc derivative commands a higher bulk price due to the upstream cost of 9-fluorenylmethyl chloroformate and the dedicated chromatographic purification required to remove the dibenzofulvene–piperidine adduct that forms during deprotection and is recycled into the Fmoc-Cl manufacturing stream. Boc-Pro-OH remains the reagent of choice for large-scale synthesis of peptide fragments destined for segment condensation, where high concentrations of trifluoroacetic acid and HF are tolerable. Cbz-Pro-OH sees limited use in contemporary SPPS but is retained in solution-phase routes where hydrogenolytic removal is convenient.

    Quality Control Parameters and Acceptance Criteria

    TestSpecificationMethod
    AppearanceWhite to off-white powderVisual, Ph.Eur. 2.2.1
    Identity (IR)Conforms to reference spectrumPh.Eur. 2.2.24
    Purity (HPLC)≥99.0% area %In-house RP-HPLC, C18, 220 nm
    Enantiomeric excess≥99.5%Chiral HPLC (Chirobiotic T) or Marfey’s deriv./RP-HPLC
    Melting range150–155 °C (dec.)Ph.Eur. 2.2.14
    Specific optical rotation−45° ± 2° (c=1, DMF)Ph.Eur. 2.2.7
    Water content≤0.3%Karl Fischer, USP <921> Method Ia
    Residual solvents1,4-Dioxane ≤0.5%; CH2Cl2 ≤0.1%Headspace GC, USP <467>
    Sulphated ash≤0.1%Ph.Eur. 2.4.14
    Heavy metals≤10 ppmPh.Eur. 2.4.8 Method C

    In a production environment equipped with a BÜCHI Sepacore® flash chromatography system and Thermo Scientific Accucore C18 HPLC guard columns, a single 50-kg batch of Fmoc-Pro-OH is typically recrystallised from ethyl acetate/n-heptane using a 200 L glass-lined reactor with jacket temperature ramped from 50 °C to −5 °C at a controlled rate of 0.3 °C/min. Filtration through a 5-μm centrifugally sealed filter-dryer yields a crystalline product with a median particle size (D50) of 180 μm as determined by laser diffraction on a Malvern Mastersizer 3000. This particle size distribution is intentionally engineered to maximise dissolution rate in DMF while minimising dust generation during automated solid dispensing on a Resolian Chemspeed SWING platform. The correlation between particle size distribution width and the uniformity of coupling in 96-well parallel peptide libraries was assessed through multivariate analysis of Kaiser test residuals; a D10–D90 span below 1.8 correlated with a per-well mass delivery CV of <3.0%.